Correlation Between Mordechai Aviv and BioLine RX
Can any of the company-specific risk be diversified away by investing in both Mordechai Aviv and BioLine RX at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mordechai Aviv and BioLine RX into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mordechai Aviv Taasiot and BioLine RX, you can compare the effects of market volatilities on Mordechai Aviv and BioLine RX and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mordechai Aviv with a short position of BioLine RX. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mordechai Aviv and BioLine RX.
Diversification Opportunities for Mordechai Aviv and BioLine RX
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Mordechai and BioLine is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Mordechai Aviv Taasiot and BioLine RX in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioLine RX and Mordechai Aviv is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mordechai Aviv Taasiot are associated (or correlated) with BioLine RX. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioLine RX has no effect on the direction of Mordechai Aviv i.e., Mordechai Aviv and BioLine RX go up and down completely randomly.
Pair Corralation between Mordechai Aviv and BioLine RX
Assuming the 90 days trading horizon Mordechai Aviv Taasiot is expected to generate 0.24 times more return on investment than BioLine RX. However, Mordechai Aviv Taasiot is 4.14 times less risky than BioLine RX. It trades about 0.02 of its potential returns per unit of risk. BioLine RX is currently generating about -0.35 per unit of risk. If you would invest 194,300 in Mordechai Aviv Taasiot on November 18, 2024 and sell it today you would earn a total of 1,100 from holding Mordechai Aviv Taasiot or generate 0.57% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mordechai Aviv Taasiot vs. BioLine RX
Performance |
| Timeline |
| Mordechai Aviv Taasiot |
| BioLine RX |
Mordechai Aviv and BioLine RX Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mordechai Aviv and BioLine RX
The main advantage of trading using opposite Mordechai Aviv and BioLine RX positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mordechai Aviv position performs unexpectedly, BioLine RX can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLine RX will offset losses from the drop in BioLine RX's long position.| Mordechai Aviv vs. Al Bad Massuot Yitzhak | Mordechai Aviv vs. Imperium Group Global | Mordechai Aviv vs. Amanet Management Systems | Mordechai Aviv vs. Gan Shmuel |
| BioLine RX vs. Evogene | BioLine RX vs. Enlivex Therapeutics | BioLine RX vs. Kamada | BioLine RX vs. Compugen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |